Lodosyn is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bausch Health Us, Llc. The primary component is Carbidopa.
| Product ID | 25010-711_1479cbeb-9172-400e-ab05-0bf145f8ca06 |
| NDC | 25010-711 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lodosyn |
| Generic Name | Carbidopa |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-04-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017830 |
| Labeler Name | Bausch Health US, LLC |
| Substance Name | CARBIDOPA |
| Active Ingredient Strength | 25 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2010-04-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA017830 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-04-13 |
| Ingredient | Strength |
|---|---|
| CARBIDOPA | 25 mg/1 |
| SPL SET ID: | ff8e105b-7415-42d4-bbb2-b36cfb8945a5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 25010-711 | Lodosyn | carbidopa |
| 16714-067 | Carbidopa | Carbidopa |
| 40032-980 | Carbidopa | Carbidopa |
| 42799-123 | Carbidopa | Carbidopa |
| 43386-980 | Carbidopa | Carbidopa |
| 43975-220 | Carbidopa | Carbidopa |
| 51407-314 | Carbidopa | Carbidopa |
| 59651-146 | Carbidopa | Carbidopa |
| 63629-1932 | Carbidopa | Carbidopa |
| 63629-9193 | Carbidopa | Carbidopa |
| 70710-1221 | CARBIDOPA | CARBIDOPA |
| 70771-1355 | CARBIDOPA | CARBIDOPA |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LODOSYN 73074989 1051094 Live/Registered |
MERCK & CO., INC. 1976-01-22 |